Kala Bio (KALA) FCF Margin (2019 - 2022)
Kala Bio (KALA) posted FCF Margin of 3738.81% for Q3 2022, down 206.81% sequentially from 1218.62% in Q2 2022, and down 287764.0% YoY from N/an in Q3 2021.
Kala Bio (KALA) FCF Margin (2019 - 2022) Analysis & Trends
Kala Bio has reported FCF Margin for 4 years, with the latest figure at 3738.81% in Q3 2022.
- Quarterly FCF Margin fell 287764.0% year-over-year to 3738.81% in Q3 2022, while the trailing twelve-month figure through Dec 2022 was 2035.48% (down 106466.0% YoY) and the FY2022 annual result came in at 2035.48%, down 106466.0% from the prior year.
- FCF Margin eased to 3738.81% in Q3 2022 per KALA's latest filing, from 1218.62% in the prior quarter.
- Over five years, FCF Margin peaked at 718.91% in Q2 2021 and troughed at 3738.81% in Q3 2022.
- A 4-year average of 1592.59% and a median of 1504.09% in 2021 frame the typical range for FCF Margin.
- The sharpest annual moves came in 2021 and 2022: FCF Margin soared 166728 bps in 2021, then plunged 287764 bps in 2022.
- Over 4 years, FCF Margin stood at 1559.32% in 2019, then grew by 24 bps to 1179.71% in 2020, then slipped by 27 bps to 1504.09% in 2021, then tumbled by 149 bps to 3738.81% in 2022.
- According to Business Quant data, FCF Margin over the past three periods registered 3738.81%, 1218.62%, and 1761.66% for Q3 2022, Q2 2022, and Q1 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -388.28% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 25.68% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 22.62% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -22.35% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 70.82% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 41.07% |
| 10 | Kala Bio | 9.87 Mn | 9.87 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | -3,738.81% |
| Jun 30, 2022 | -1,218.62% |
| Mar 31, 2022 | -1,761.66% |
| Dec 31, 2021 | -1,504.09% |
| Sep 30, 2021 | -861.17% |
| Jun 30, 2021 | -718.91% |
| Mar 31, 2021 | -1,006.09% |
| Dec 31, 2020 | -1,179.71% |
| Sep 30, 2020 | -1,179.50% |
| Jun 30, 2020 | -2,386.19% |
| Mar 31, 2020 | -1,883.47% |
| Dec 31, 2019 | -1,559.32% |
| Sep 30, 2019 | -1,593.11% |
| Jun 30, 2019 | -1,017.26% |
| Mar 31, 2019 | -2,280.95% |